Luxembourg at the heart of international immunometabolism research

LIH hosts successful 2nd European Immunometabolism Network Conference

• Department of Infection and Immunity
• Experimental and Molecular Immunology

From 10 to 12 June 2026, Luxembourg welcomed 170 researchers, clinicians and young scientists from across Europe and beyond for the 2^nd European Immunometabolism Network Conference (EIMN 2026). Hosted by the Luxembourg Institute of Health (LIH), the event brought together the international immunometabolism community to discuss the latest scientific advances at the intersection of metabolism and immune function.

Immunometabolism explores the intricate relationship between metabolism and the immune system, unravelling how cellular metabolism influences immune cell activation, differentiation, and effector functions. This emerging field has important implications for the understanding of various diseases, including cancer, autoimmune disorders, and metabolic disorders.

Over three days, attendees explored how metabolic processes influence immune responses in health and disease. Scientific sessions covered a wide range of topics, including cancer immunology, inflammation, infection, autoimmune diseases and emerging therapeutic approaches. The programme also featured renowned speakers from leading academic and research institutions.

A major driving force behind the conference was Prof. Dirk Brenner, leader of the Experimental & Molecular Immunology group at the LIH Department of Infection and Immunity (DII) and one of Europe’s leading experts in immunometabolism. As the chair of EIMN 2026, Prof. Brenner played a central role in shaping the scientific programme and brought together an outstanding panel of speakers and participants.

“The event highlighted the truly international nature of the immunometabolism community. We welcomed 170 researchers from 21 countries, creating opportunities for new collaborations and strengthening existing scientific networks. The conference also provided a valuable platform for early-career researchers, giving them the opportunity to present their work, engage with internationally recognised experts and expand their professional networks”, said Prof. Brenner.

By hosting EIMN 2026, the LIH further reinforced its position as a key contributor to European biomedical research and demonstrated Luxembourg’s growing status as a destination for high-level scientific events. The success of the conference underscored the importance of international cooperation in tackling complex health challenges and advancing our understanding of the links between metabolism and immunity.

The LIH would like to thank all of the speakers, participants, sponsors and partners whose contributions made EIMN 2026 a memorable and impactful conference.